NCT05249114 2026-04-13Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine TumorsProvidence Health & ServicesPhase 1 Active not recruiting6 enrolled
NCT04261855 2026-03-27GoTHAMMelanoma and Skin Cancer Trials LimitedPhase 1/2 Active not recruiting19 enrolled